Pure Global

Testosterone - India CDSCO Medical Device Registration

Testosterone is a medical device registered with India's Central Drugs Standard Control Organization (CDSCO) under UID IMP/IVD/2021/000365_eecae0ffd3deb98e06545eff056833f9_b1112a1060a43b6fa831e65ff1f49752. This device is marketed under the brand name AFIAS Infliximab . The license holder is BODITECH MED INDIA PRIVATE LIMITED, and it is classified as Device Class Class B. The approving authority is CDSCO.

This page provides comprehensive regulatory information including complete registration details, license holder information, device classification, and related products. Pure Global AI offers free access to 71,807+ India medical device registrations, helping global MedTech companies identify partners, analyze markets, and discover business opportunities efficiently.

Free Database
Powered by Pure Global AI
CDSCO Registered
Class Class B
Testosterone
UID: IMP/IVD/2021/000365_eecae0ffd3deb98e06545eff056833f9_b1112a1060a43b6fa831e65ff1f49752

Brand Name

AFIAS Infliximab

Device Class

Class B

Approving Authority

CDSCO

Product Information

AFIAS Testosterone is a fluorescence Immunoassay (AFIAS Infliximab ) for the quantitative determination of Testosterone in human serum/plasma. It is useful as an aid in management and monitoring of androgen level. For in vitro diagnostic use only

Pure Global
DJ Fang

DJ Fang

MedTech Regulatory Expert

Need help with 30+ markets registration?

Pricing